| Execution period | 5 years |
|---|
BSE filing, BSE: 544708. Summary written from the filing by ALFA Finder's alert engine.
Yashhtej Industries (India) Ltd: key numbers
- Share price
- ₹45.82
- Market cap
- ₹105.8 Cr
- Revenue (annual)
- ₹269.4 Cr
- Net profit (annual)
- ₹12.53 Cr
- P/E (TTM)
- 8.4×Sector 26.8×
- Promoter holding
- 64.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yashhtej Industries (India) Ltd
All →Yashhtej Industries (India) Other Announcement
Yashhtej Industries (India) Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Yashhtej Industries (India) Legal & Regulatory
Yashhtej Industries received an order from the Regional Director, MCA, imposing a total penalty of ₹0.012 Crore on the company and its directors.
- Value
- ₹0.01 Cr
Yashhtej Industries (India) Management Change
Yashhtej Industries (India) Limited has appointed M/s. H M Kadeval & Associates as Secretarial Auditor for a term of 60 months, effective September 29, 2026.
Yashhtej Industries (India) Annual General Meeting
Yashhtej Industries held its 8th Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements, director appointments, and other routine business.
Yashhtej Industries (India) Annual Report
The company has submitted its Annual Report for the financial year 2025-2026, alongside the notice for its 8th Annual General Meeting (AGM). The AGM is scheduled for September 29, 2026.
Yashhtej Industries (India) Annual General Meeting
Yashhtej Industries will hold its 8th Annual General Meeting on September 29, 2026, via video conferencing to transact business.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.